GTCR to sell stem cell company to AMAG for $700m
The private equity firm initially invested in Cord Blood Registry in 2012 through its Fund X
Home Private Equity News & Analysis Private Equity Deals & Transactions GTCR to sell stem cell company to AMAG for $700m
